[
    [
        {
            "time": "2023-08-02",
            "original_text": "[快讯]健帆生物30626万股限售股8月2日解禁 解禁",
            "features": {
                "keywords": [
                    "健帆生物",
                    "限售股",
                    "解禁",
                    "30626万股",
                    "8月2日"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[快讯]健帆生物30626万股限售股8月2日解禁 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-08-02",
            "original_text": "健帆生物(300529.SZ)：约3.06亿股限售股8月2日解禁 解禁",
            "features": {
                "keywords": [
                    "健帆生物",
                    "限售股",
                    "解禁",
                    "3.06亿股",
                    "8月2日"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：约3.06亿股限售股8月2日解禁 解禁",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-08-02",
            "original_text": "健帆生物：3.06亿股限售股解禁，占公司总股本比例73.12% 解禁",
            "features": {
                "keywords": [
                    "健帆生物",
                    "限售股",
                    "解禁",
                    "3.06亿股",
                    "73.12%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：3.06亿股限售股解禁，占公司总股本比例73.12% 解禁",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]